Bank of Montreal’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,000
| Closed | -$182K | – | 3859 |
|
|
2026
Q1 | $182K | Buy |
+3,000
| New | +$175K | ﹤0.01% | 2960 |
|
|
2025
Q1 | – | Sell |
-58,000
| Closed | -$3.28M | – | 3504 |
|
|
2024
Q4 | $3.28M | Buy |
58,000
+12,400
| +27% | +$693K | ﹤0.01% | 1371 |
|
|
2024
Q3 | $2.32M | Buy |
+45,600
| New | +$2.14M | ﹤0.01% | 1635 |
|
|
2023
Q2 | – | Sell |
-40,000
| Closed | -$2.84M | – | 3984 |
|
|
2023
Q1 | $2.84M | Sell |
40,000
-145,000
| -78% | -$10.2M | ﹤0.01% | 1507 |
|
|
2022
Q4 | $14.7M | Hold |
185,000
| – | – | 0.01% | 815 |
|
|
2022
Q3 | $13.3K | Buy |
185,000
+40,000
| +28% | +$2.9M | 0.01% | 853 |
|
|
2022
Q2 | $11.7K | Hold |
145,000
| – | – | 0.01% | 998 |
|
|
2022
Q1 | $10.7M | Buy |
+145,000
| New | +$9.74M | 0.01% | 1112 |
|
|
2021
Q1 | – | Sell |
-411,600
| Closed | -$26.7M | – | 5075 |
|
|
2020
Q4 | $26.7M | Buy |
+411,600
| New | +$25.3M | 0.02% | 602 |
|
|
2020
Q2 | – | Sell |
-164,500
| Closed | -$9.08M | – | 4631 |
|
|
2020
Q1 | $9.08M | Sell |
164,500
-135,500
| -45% | -$8.28M | 0.01% | 734 |
|
|
2019
Q4 | $19.3M | Buy |
300,000
+150,000
| +100% | +$8.59M | 0.01% | 701 |
|
|
2019
Q3 | $7.61M | Buy |
+150,000
| New | +$7.05M | 0.01% | 988 |
|
|
2019
Q2 | – | Sell |
-203,800
| Closed | -$9.72M | – | 4863 |
|
|
2019
Q1 | $9.72M | Buy |
203,800
+181,800
| +826% | +$9.06M | 0.01% | 859 |
|
|
2018
Q4 | $1.14M | Buy |
+22,000
| New | +$1.18M | ﹤0.01% | 1829 |
|
|
2017
Q2 | – | Sell |
-1,713,000
| Closed | -$93.2M | – | 4142 |
|
|
2017
Q1 | $93.2M | Buy |
+1,713,000
| New | +$94M | 0.09% | 191 |
|
|
2016
Q1 | – | Sell |
-500
| Closed | -$34K | – | 4192 |
|
|
2015
Q4 | $34K | Hold |
500
| – | – | ﹤0.01% | 3182 |
|
|
2015
Q3 | $30K | Sell |
500
-14,500
| -97% | -$920K | ﹤0.01% | 3097 |
|
|
2015
Q2 | $998K | Sell |
15,000
-500
| -3% | -$33K | ﹤0.01% | 1668 |
|
|
2015
Q1 | $1M | Sell |
15,500
-20,000
| -56% | -$1.25M | ﹤0.01% | 1645 |
|
|
2014
Q4 | $2.1M | Buy |
+35,500
| New | +$2M | ﹤0.01% | 1392 |
|
|
2014
Q2 | – | Sell |
-8,925
| Closed | -$464K | – | 4677 |
|
|
2014
Q1 | $464K | Buy |
+8,925
| New | +$475K | ﹤0.01% | 2091 |
|
|
2013
Q4 | – | Sell |
-4,964
| Closed | -$230K | – | 3729 |
|
|
2013
Q3 | $230K | Buy |
+4,964
| New | +$218K | ﹤0.01% | 2176 |
|
Other funds holding BMY
Bank of Montreal's BMY Position: Q2 2026 in Review
Bank of Montreal increased its Bristol-Myers Squibb (BMY) stake by 17% in Q2 2026, buying an estimated $23.4M and bringing the position to 2,777,169 shares worth $160M. The position accounts for 0.05% of the portfolio, ranked #288.
Bank of Montreal first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $475M in Q4 2020. 1,876 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Bank of Montreal held 2,777,169 shares of Bristol-Myers Squibb worth $160M as of Q2 2026.
- Bank of Montreal bought 408,084 Bristol-Myers Squibb shares in Q2 2026, an estimated $23.4M.
- Bristol-Myers Squibb made up 0.05% of Bank of Montreal's portfolio in Q2 2026, its #288 holding.
- Bank of Montreal first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Bank of Montreal's Bristol-Myers Squibb position peaked at $475M in Q4 2020.
- 1,876 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.